NASDAQ:KLRS | Cash Flow Statement | Kalaris Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$11.52M
2026-03-31-$10.86M-$11.58M-$50.35M-$1.7M
2025-12-31-$10M-$7.06M$17,000.00$14.98M$47.74M
2025-09-30-$11.89M
2025-06-30-$11.35M
2025-03-31-$10.2M-$7.44M$107.27M
2024-12-31-$22.03M-$7.85M$5M$7.58M
2024-09-30-$38.08M
2024-06-30-$5.65M
2024-03-31-$3.41M-$4.52M$40M$6.58M
2023-12-31-$59.7M$141,000.00-$30.74M$25.22M$11,000.00
2023-09-30-$44.27M
2023-06-30-$45.27M
2023-03-31-$41.18M$86,000.00-$32.12M$41.72M
2022-12-31-$38.14M$86,000.00-$31.57M$13.54M$292,000.00
2022-09-30-$42.07M
2022-06-30-$44.64M
2022-03-31-$43.86M$466,000.00-$46.48M-$54.98M
2021-12-31-$57.94M$94,000.00-$28.07M-$370,000.00-$13.52M$65,000.00
2021-09-30-$45.51M
2021-06-30-$37.59M
2021-03-31-$30.92M$18,000.00-$18.93M$75,000.00$64.83M
2020-12-31-$25.2M$18,000.00-$21.09M$1.92M-$354,000.00
2020-09-30-$23.61M
2020-06-30-$11.63M
2020-03-31-$9.34M$18,000.00-$10.54M$13.84M
2019-12-31-$8.74M-$8.87M$121,000.00$34.88M$0.00
2019-09-30-$7.27M
2019-06-30-$5.3M
2019-03-31-$2.52M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$43.44M-$38.37M$200,000.00-$19.72M$155.01M
2024-12-31-$69.17M-$20.67M$95M$19.14M
2023-12-31-$190.42M$398,000.00-$124.45M$37.99M$70.5M
2022-12-31-$168.71M$723,000.00-$142.05M-$80.48M$126.96M
2021-12-31-$171.96M$189,000.00-$106.32M$26,000.00$185.98M$232,000.00
2020-12-31-$69.78M$73,000.00-$60.81M$235,000.00-$169.5M$291.98M
2019-12-31-$23.84M$19,000.00-$20.16M$339,000.00-$64.64M$120.92M